Christopher Bulow
Gründer bei ResistanceBio, Inc.
Profil
Christopher Bulow founded Viosera Therapeutics Inc. in 2016, where he worked as Chief Operating Officer.
Dr. Bulow also founded resistanceBio, Inc., where he worked as Chief Financial Officer & Director.
Aktive Positionen von Christopher Bulow
| Unternehmen | Position | Beginn |
|---|---|---|
ResistanceBio, Inc.
 ResistanceBio, Inc. BiotechnologyHealth Technology ResistanceBio, Inc. is a company that focuses on overcoming treatment-resistant cancer. The company is based in San Carlos, CA. The company's mission is to defeat this type of cancer by developing a novel class of multi-targeted oncology treatments called Resistance Suppressing Therapy (REST). ResistanceBio was founded by Nicholas Goldner and Christopher Bulow, with Nicholas Goldner serving as the CEO since incorporation. | Gründer | - |
Ehemalige bekannte Positionen von Christopher Bulow
| Unternehmen | Position | Ende |
|---|---|---|
Viosera Therapeutics Inc.
 Viosera Therapeutics Inc. Miscellaneous Commercial ServicesCommercial Services Viosera Therapeutics Inc. engages in the research and develop services that predict and block drug resistance in cancer and bacteria. The company was founded by Christopher Bulow and Nicholas Goldner and is headquartered in St. Louis, MO. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Viosera Therapeutics Inc.
Viosera Therapeutics Inc. Miscellaneous Commercial ServicesCommercial Services Viosera Therapeutics Inc. engages in the research and develop services that predict and block drug resistance in cancer and bacteria. The company was founded by Christopher Bulow and Nicholas Goldner and is headquartered in St. Louis, MO. | Commercial Services |
ResistanceBio, Inc.
ResistanceBio, Inc. BiotechnologyHealth Technology ResistanceBio, Inc. is a company that focuses on overcoming treatment-resistant cancer. The company is based in San Carlos, CA. The company's mission is to defeat this type of cancer by developing a novel class of multi-targeted oncology treatments called Resistance Suppressing Therapy (REST). ResistanceBio was founded by Nicholas Goldner and Christopher Bulow, with Nicholas Goldner serving as the CEO since incorporation. | Health Technology |
